LaserSight Revamping Website Following FDA Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
LaserSight Technologies says it is exploring various options to differentiate statements made for international versus U.S. website users in the wake of a May 12 warning letter from FDA.